Now in 2023 as ESG has transitioned from a value adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to brand new global regulations and position your life sciences organization for future success.

The 2nd Annual ESG in Life Sciences Summit joined the most forward thinking ESG, EHS, sustainability, CSR leaders as well as other key stakeholders at as they uncovered how to operationally embed ESG and sustainability across your biopharma business and tackle industry-specific challenges such as health equity to satisfy future employees, customers, and investors.

This unique and much needed event was the only opportunity to understand how life sciences organizations of all sizes and stages in the US are successfully developing and driving a successful sustainable business strategy now to truly deliver on (science based) targets and commitments.